COMMUNIQUÉS West-GlobeNewswire

Sanofi: Informations relatives au nombre de droits de vote et d'actions – Septembre 2026
12/10/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares – September 2026
12/10/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Pasatru™ (garetosmab-grts) Demonstrates Zero New Heterotopic Ossification (HO) Lesions in Adult Fibrodysplasia Ossificans Progressiva (FOP) Patients During OPTIMA Trial Extension
12/10/2026
Pasatru is the first and only FDA-approved treatment demonstrating reductions in both new HO lesions and clinician-assessed flare-ups, per results of a 56-week placebo-controlled trial in adults with FOP Late-breaking [...]
AB Science tiendra une web conférence le mercredi 14 octobre 2026 de 18h à 19h30
12/10/2026
COMMUNIQU É DE PRESSE AB SCIENCE TIENDRA UNE WEB CONFÉRENCE LE MERCREDI 14 OCTOBRE DE 18H A 19H30 Paris, 12 octobre 2026, 18h AB Science SA (Euronext - FR0010557264 - AB) tiendra une web conférence le mercredi 14 [...]
AB Science will hold a web conference on Wednesday, October 14, 2026, from 6:00 p.m. to 7:30 p.m.
12/10/2026
PRESS RELEASE AB SCIENCE WILL HOLD A WEB CONFERENCE ON WEDNESDAY, OCTOBER 14, FROM 6:00 P.M. TO 7:30 P.M. Paris, October 12, 2026, 6:00 p.m. AB Science SA (Euronext - FR0010557264 - AB) will hold a web conference on [...]
Diazyme Laboratories, Inc. Acquires Alfa Wassermann Diagnostic Technologies LLC.
12/10/2026
POWAY, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. announced today that it has acquired the business of Alfa Wassermann Diagnostic Technologies LLC. (AWDT) from CARR Biosystems. AWDT is an FDA [...]
AnewHealth and IntusCare Announce Advanced, Bidirectional Integration to Simplify Medication Management for PACE Programs
12/10/2026
The integration of AnewHealth's EireneRx® and IntusCare’s CareHub EMR, two platforms purpose-built for PACE, will connect participant and medication information to help create a more seamless experience for PACE care [...]
IM8 Named Official Nutrition Partner of the NBA in Australia and Southeast Asia
12/10/2026
Photo: IM8 co-founder David Beckham; two-time NBA champion Chris Bosh; IM8 chief of staff and brand partnerships Samantha Kwok; and NBA executives (Credit: NBA) – IM8 will Host Fan Activation at an NBA House in the [...]
Aro Biotherapeutics Reports Therapeutic Potential of Centyrin – IFIH1 siRNA Conjugate for the Treatment of Type 1 Diabetes
12/10/2026
Oral presentation at the Breakthrough T1D Clinical & Research Congress highlights preclinical studies showing reduced blood glucose levels, delayed disease onset, and improved survival in a Type 1 diabetes mouse [...]
Ozari Health Expands Nationwide GLP-1 Telehealth Platform With Two Plans for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month
12/10/2026
LegitScript-certified platform now offers Ozari One, compounded semaglutide with B12 at $86 per month and tirzepatide with B12 at $125 per month, and Ozari Select, with a choice of formulation, billing term, and [...]
Baylor Genetics to Showcase How Genome Sequencing is Advancing Pediatric Care at the 2026 Child Neurology Society Annual Meeting
12/10/2026
HOUSTON, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will highlight the [...]
Waylo Ahead Launches Initiative for Young Drivers Beyond the Test
12/10/2026
SYDNEY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Waylo Ahead today announced the launch of a global road-safety initiative designed to help families close the gap between passing the driving test and being prepared to drive [...]
Alignment Health Launches New Medicare Advantage Plan Designed for Asian American Seniors in Los Angeles and Orange Counties
12/10/2026
New Central Health Harmony plan offers access to more than 600 Chinese-, Korean- and Vietnamese-speaking physicians, culturally tailored benefits and leading provider partners including Astrana Health ORANGE, Calif., [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
12/10/2026
COPENHAGEN, Denmark, October 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on September 1, 2026, under which the Company will repurchase shares for an amount [...]
MediciNova CEO Provides Shareholder Update
12/10/2026
LA JOLLA, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
BSACI 2026: New preference and ease-of-use data comparing EURneffy® nasal adrenaline spray and adrenaline auto-injector trainer devices
12/10/2026
New UK comparative study data assessing patient preferences between trainer devices suggest EUR neffy ® is viewed as less burdensome than adrenaline auto-injectors (AAIs) 1 After trying both trainer devices, patients [...]
Novo Nordisk A/S - share repurchase programme
12/10/2026
Bagsværd, Denmark, 12 October 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 Annual Meeting
12/10/2026
Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline in CST with statistical significance 1 at 6 months, and these changes were maintained at 24 months (a [...]
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease
12/10/2026
ANB033 achieved a statistically significant and clinically meaningful protective effect on both gluten-induced intestinal damage and symptoms LS mean change from baseline in Vh:Cd ratio of -0.17 on ANB033 vs. -0.66 on [...]

Pages